Daniel Canter

5.8k total citations
140 papers, 3.7k citations indexed

About

Daniel Canter is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Daniel Canter has authored 140 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Pulmonary and Respiratory Medicine, 68 papers in Surgery and 29 papers in Molecular Biology. Recurrent topics in Daniel Canter's work include Renal cell carcinoma treatment (44 papers), Bladder and Urothelial Cancer Treatments (42 papers) and Urinary and Genital Oncology Studies (22 papers). Daniel Canter is often cited by papers focused on Renal cell carcinoma treatment (44 papers), Bladder and Urothelial Cancer Treatments (42 papers) and Urinary and Genital Oncology Studies (22 papers). Daniel Canter collaborates with scholars based in United States, Canada and Australia. Daniel Canter's co-authors include Alexander Kutikov, Robert G. Uzzo, Marc C. Smaldone, David Y.T. Chen, Rosalia Viterbo, Richard E. Greenberg, Jay Simhan, Brian L. Egleston, Thomas J. Guzzo and Pasquale Casale and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Cancer.

In The Last Decade

Daniel Canter

136 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Canter United States 32 2.0k 1.5k 1.3k 506 497 140 3.7k
Wade J. Sexton United States 32 2.1k 1.1× 1.7k 1.2× 858 0.7× 466 0.9× 860 1.7× 194 4.2k
Byong Chang Jeong South Korea 33 2.3k 1.2× 1.3k 0.9× 1.2k 0.9× 491 1.0× 676 1.4× 248 4.1k
Seong Soo Jeon South Korea 31 2.3k 1.1× 1.0k 0.7× 905 0.7× 418 0.8× 549 1.1× 240 3.6k
Reza Mehrazin United States 30 1.4k 0.7× 1.3k 0.9× 942 0.7× 308 0.6× 566 1.1× 175 2.7k
Tsunenori Kondo Japan 30 1.2k 0.6× 727 0.5× 609 0.5× 145 0.3× 1.5k 3.1× 131 2.9k
Y. Neuzillet France 29 1.6k 0.8× 3.9k 2.7× 1.2k 0.9× 1.2k 2.5× 1.2k 2.4× 201 5.4k
Amlesh Seth India 35 2.2k 1.1× 1.1k 0.8× 925 0.7× 689 1.4× 489 1.0× 231 4.3k
Giancarlo Marra Italy 27 1.3k 0.6× 460 0.3× 301 0.2× 427 0.8× 326 0.7× 139 2.4k
Derek Manas United Kingdom 39 1.1k 0.5× 2.4k 1.6× 356 0.3× 24 0.0× 1.2k 2.4× 199 5.1k
Alexander Barsouk United States 15 1.1k 0.5× 702 0.5× 1.1k 0.9× 69 0.1× 1.0k 2.1× 23 3.2k

Countries citing papers authored by Daniel Canter

Since Specialization
Citations

This map shows the geographic impact of Daniel Canter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Canter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Canter more than expected).

Fields of papers citing papers by Daniel Canter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Canter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Canter. The network helps show where Daniel Canter may publish in the future.

Co-authorship network of co-authors of Daniel Canter

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Canter. A scholar is included among the top collaborators of Daniel Canter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Canter. Daniel Canter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Worobey, Lynn A., Daniel Canter, Denise Fyffe, et al.. (2024). Wheelchair Repairs: Delays, Causes, and Associated Outcomes. Archives of Physical Medicine and Rehabilitation. 106(3). 379–386.
2.
Tward, Jonathan D., Thorsten Schlomm, Daniel Canter, et al.. (2021). Personalizing Localized Prostate Cancer: Validation of a Combined Clinical Cell-cycle Risk (CCR) Score Threshold for Prognosticating Benefit From Multimodality Therapy. Clinical Genitourinary Cancer. 19(4). 296–304.e3. 11 indexed citations
3.
Matrana, Marc, et al.. (2020). A Contemporary Analysis of the 30-day Morbidity and Mortality Associated With Cytoreductive Nephrectomy. Urology. 147. 186–191. 8 indexed citations
4.
Schilling, Amber, et al.. (2019). Adrenalectomy: should urologists not be doing more?. International Urology and Nephrology. 52(2). 197–204. 4 indexed citations
5.
6.
Bateni, Sarah B., et al.. (2017). The modified frailty index to predict morbidity and mortality for retroperitoneal sarcoma resections. Journal of Surgical Research. 217. 191–197. 13 indexed citations
7.
8.
Tomaszewski, Jeffrey, Robert G. Uzzo, Neil J. Kocher, et al.. (2014). Patients with anatomically “simple” renal masses are more likely to be placed on active surveillance than those with anatomically “complex” lesions. Urologic Oncology Seminars and Original Investigations. 32(8). 1267–1271. 12 indexed citations
9.
Seideman, Casey A., Daniel Canter, Philip Kim, et al.. (2014). Multicenter evaluation of the role of UroVysion FISH assay in surveillance of patients with bladder cancer: does FISH positivity anticipate recurrence?. World Journal of Urology. 33(9). 1309–1313. 35 indexed citations
10.
Sleemi, Ambereen, et al.. (2012). Use of a Low-Pressure Colonic Pouch (Mainz II) Urinary Diversion for Irreparable Vesico-vaginal Fistula and Bladder Extrophy in Eritrea.
11.
Johnson, Timothy V., Wayland Hsiao, Keith A. Delman, Daniel Canter, & Viraj A. Master. (2012). Scrotal cancer survival is influenced by histology: a SEER study. World Journal of Urology. 31(3). 585–590. 15 indexed citations
12.
Teper, Ervin, Peter Makhov, Konstantin Golovine, et al.. (2012). The Effect of 5-Aminolevulinic Acid and Its Derivatives on Protoporphyrin IX Accumulation and Apoptotic Cell Death in Castrate-resistant Prostate Cancer Cells. Urology. 80(6). 1391.e1–1391.e7. 7 indexed citations
13.
Smaldone, Marc C., Alexander Kutikov, Brian L. Egleston, et al.. (2012). Assessing Performance Trends in Laparoscopic Nephrectomy and Nephron-sparing Surgery for Localized Renal Tumors. Urology. 80(2). 286–292. 40 indexed citations
14.
Golovine, Konstantin, Peter Makhov, Ervin Teper, et al.. (2012). Piperlongumine induces rapid depletion of the androgen receptor in human prostate cancer cells. The Prostate. 73(1). 23–30. 57 indexed citations
15.
Canter, Daniel, Jay Simhan, Marc C. Smaldone, et al.. (2011). Clinical Stage T1 Micropapillary Urothelial Carcinoma Presenting With Metastasis to the Pancreas. Urology. 79(2). e9–e10. 2 indexed citations
16.
Kutikov, Alexander, Peter Makhov, Konstantin Golovine, et al.. (2011). Interleukin-6: A Potential Biomarker of Resistance to Multitargeted Receptor Tyrosine Kinase Inhibitors in Castration-resistant Prostate Cancer. Urology. 78(4). 968.e7–968.e11. 20 indexed citations
17.
Makhov, Peter, Alexander Kutikov, Konstantin Golovine, et al.. (2011). Docetaxel‐mediated apoptosis in myeloid progenitor TF‐1 cells is mitigated by zinc: Potential implication for prostate cancer therapy. The Prostate. 71(13). 1413–1419. 14 indexed citations
18.
Kutikov, Alexander, Marc C. Smaldone, Brian L. Egleston, et al.. (2011). Anatomic Features of Enhancing Renal Masses Predict Malignant and High-Grade Pathology: A Preoperative Nomogram Using the RENAL Nephrometry Score. European Urology. 60(2). 241–248. 192 indexed citations
19.
Canter, Daniel, Jay Simhan, Karen Wu, Robert G. Uzzo, & Alexander Kutikov. (2011). Intensely Positron Emission Tomography-avid Benign Adrenal Adenoma. Urology. 78(6). 1307–1308. 3 indexed citations
20.
Hance, Kenneth W., Connie J. Rogers, David A. Zaharoff, et al.. (2009). The Antitumor and Immunoadjuvant Effects of IFN-α in Combination with Recombinant Poxvirus Vaccines. Clinical Cancer Research. 15(7). 2387–2396. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wade J. Sexton Breakdown of academic impact, for papers by Byong Chang Jeong Breakdown of academic impact, for papers by Seong Soo Jeon Breakdown of academic impact, for papers by Reza Mehrazin Breakdown of academic impact, for papers by Tsunenori Kondo Breakdown of academic impact, for papers by Y. Neuzillet Breakdown of academic impact, for papers by Amlesh Seth Breakdown of academic impact, for papers by Giancarlo Marra Breakdown of academic impact, for papers by Derek Manas Breakdown of academic impact, for papers by Alexander Barsouk
Rankless by CCL
2026